Sotera Health Co(SHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 34 | EPS (ttm) | 0.57 | Insider Own | 2.1% | Shs Outstand | 285.4M | Perf Week | 5.46% |
| Market Cap | 5.52B | Forward P/E | 17.98 | EPS next Y | 9.16% | Insider Trans | -89.71% | Shs Float | 279.4M | Perf Month | 2.82% |
| Enterprise Value | 7.43B | PEG | 1.59 | EPS next Q | 0.27 | Inst Own | 103.09% | Short Float | 4.28% | Perf Quarter | 20.51% |
| Income | 0.16B | P/S | 4.54 | EPS this Y | 14.49% | Inst Trans | 1.21% | Short Ratio | 4.46 | Perf Half Y | 39.57% |
| Sales | 1.22B | P/B | 8.29 | EPS next 5Y | 11.33% | ROA | 5.01% | Short Interest | 11.96M | Perf YTD | 9.58% |
| Book/sh | 2.33 | P/C | 15.46 | EPS past 3/5Y | - | ROE | 27.78% | 52W High | -2.62% ($19.85) | Perf Year | 18.59% |
| Cash/sh | 1.25 | P/FCF | 50.25 | Sales past 3/5Y | 5.05% 7.3% | ROIC | 5.62% | 52W Low | 47.67% ($13.09) | Perf 3Y | 24.31% |
| Dividend Est. | $0.01 (0.05%) | EV/EBITDA | 12.89 | EPS Y/Y TTM | 576.89% | Gross Margin | 53.97% | Volatility(W/M) | 2.22% 2.27% | Perf 5Y | -24.26% |
| Dividend TTM | - | EV/Sales | 6.11 | Sales Y/Y TTM | 8.15% | Oper. Margin | 36.9% | ATR (14) | 0.46 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.53 | EPS Q/Q | 567.38% | Profit Margin | 13.44% | RSI (14) | 59.86 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.8 | Sales Q/Q | 9.18% | SMA20 | 1.84% ($18.98) | Beta | 1.85 | Target Price | $22.72 |
| Payout | - | Debt/Eq | 3.41 | Earnings | 2026/8/6 | SMA50 | 4.69% ($18.46) | Rel Volume | 1.06 | Prev Close | $18.98 |
| Employees | 3000 | LT Debt/Eq | 3.37 | EPS/Sales Surpr. | 8.83% 3.77% | SMA200 | 14.44% ($16.89) | Avg Volume(3M) | 2.68M | Price | $19.33 |
| IPO | 2020/11/20 | Option/Short | Yes/Yes | Trades | 24478 | Volume | 2,838,968 | Change | 1.84% |
Company
SHC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🧪 A global healthcare services company that provides sterilization and laboratory testing services for the medical device and pharmaceutical industries. It offers gamma, ethylene oxide, and electron beam sterilization along with laboratory testing and consulting services, serving as essential infrastructure for the medical device and pharmaceutical industries. The business is characterized by a stable structure based on non-discretionary demand.
Over the past 1 year, on the higher side
3% below its 1-year high.
SHC makes money exceptionally well
36.9% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.5% this year.
Tap to view numbers
The price looks about right
Trading at 34.0 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +24.3% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.05% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 103.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
MIGO 0.02%
BSMC 0.01%
ODHY 0.01%
XHYH 0.01%
PIPE 0.01%It ranks #4 in the industry
Based on market cap of $6B.
SHC $6B PER 34.0
TMO $240B PER 34.9
DHR $146B PER 37.0
NTRA $50B PER -
FAQ
What kind of company is SHC?
SHC belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of SHC?
The market cap of SHC is approximately $5.5B, ranking 1,304 within its sector.
Does SHC pay dividends?
SHC has a dividend yield of approximately 0.05%, with an annual dividend of $0.01.
What is the P/E ratio of SHC?
SHC has a P/E ratio of approximately 34.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SHC?
SHC has recorded a 52-week high of $19.85 and a low of $13.09.
